Healthcare Sector Insider Trading Activity

Track insider buying and selling in Healthcare stocks. See which executives are buying, net insider activity, and % of float traded across 3,246 companies.
The information provided in this screen is for informational purposes only and does not constitute financial advice. We do not endorse any specific investment based on these criteria.
Companies
Data
Subscribe to access full data
Company Business Sector Market cap ($) # net buying insiders Net value bought ($) % of float bought % of shares held by insiders
Pharmaceuticals & Medical Research Mid (2.2bn) 0 No activity — 15–50%
FR Orpea SA (ORP)
Healthcare Services Mid (2.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (2.1bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (2.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) -1–5 -$100K–$1M -0–15% 0–15%
BE Fagron NV (FAGR)
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No activity — 0–15%
Healthcare Services Mid (2.1bn) 0 No activity — 0–15%
AU Ansell Ltd (ANN)
Healthcare Services Mid (2.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No activity — 15–50%
CH Idorsia Ltd (IDIA)
Pharmaceuticals & Medical Research Mid (2.1bn) -1–5 -< $100K -0–15% 15–50%
US Zymeworks Inc (ZYME)
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No activity — 0–15%
Healthcare Services Mid (2.1bn) 0 No activity — 15–50%
SE AddLife AB (ALIF-B)
Pharmaceuticals & Medical Research Mid (2.1bn) 1–5 < $100K 0–15% 0–15%
Healthcare Services Mid (2.1bn) 0 No activity — 0–15%
IN Shilpa Medicare Ltd (SHILPAMED)
Pharmaceuticals & Medical Research Mid (2.1bn) -1–5 -< $100K -0–15% 50%+
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No activity — 0–15%
US NuVasive Inc (NUVA)
Healthcare Services Mid (2.1bn) 0 No activity — 0–15%
CH BB Biotech AG (BION)
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No activity — 15–50%
Healthcare Services Mid (2.1bn) 1–5 $100K–$1M 0–15% 0–15%
US Xencor Inc (XNCR)
Pharmaceuticals & Medical Research Mid (2.1bn) 0 No activity — 0–15%
Healthcare Services Mid (2.1bn) -1–5 -< $100K -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (2.0bn) 0 No activity — 0–15%
Healthcare Services Mid (2.0bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (2.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (2.0bn) -1–5 -< $100K -0–15% 0–15%
US Progyny Inc (PGNY)
Healthcare Services Mid (2.0bn) -1–5 -$100K–$1M -0–15% 0–15%
IN Jubilant Pharmova Ltd (JUBLPHARMA)
Pharmaceuticals & Medical Research Mid (2.0bn) 0 No activity — 50%+
SE Elekta AB (publ) (EKTA-B)
Healthcare Services Mid (2.0bn) 1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (2.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (2.0bn) 0 No activity — 0–15%
US Quidel Corp (QDEL)
Healthcare Services Small (2.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (2.0bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Small (1.9bn) 0 No activity — 0–15%
Healthcare Services Small (1.9bn) 0 No activity — 0–15%
GB Genus PLC (GNS)
Pharmaceuticals & Medical Research Small (1.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.9bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Small (1.9bn) 0 No activity — 15–50%
SE Vimian Group AB (VIMIAN)
Healthcare Services Small (1.9bn) 0 $10M–$100M 50%+ 0–15%
Pharmaceuticals & Medical Research Small (1.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.9bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Small (1.9bn) 0 No activity — 0–15%
Healthcare Services Small (1.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.9bn) -1–5 -< $100K -0–15% 0–15%
Healthcare Services Small (1.9bn) 0 No activity — 0–15%
Healthcare Services Small (1.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 0 No activity — 0–15%
Healthcare Services Small (1.8bn) -1–5 -$10M–$100M -0–15% 0–15%
US Septerna Inc (SEPN)
Pharmaceuticals & Medical Research Small (1.8bn) 0 No activity — 0–15%
Healthcare Services Small (1.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 0 No activity — 0–15%
US Biohaven Ltd (BHVN)
Pharmaceuticals & Medical Research Small (1.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) -1–5 -$10M–$100M -0–15% 0–15%
BE Galapagos NV (GLPG)
Pharmaceuticals & Medical Research Small (1.8bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Small (1.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) -1–5 -$100K–$1M -0–15% 0–15%
US Novavax, Inc. (NVAX)
Pharmaceuticals & Medical Research Small (1.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 0 No activity — 0–15%
Healthcare Services Small (1.8bn) 0 No activity — 0–15%
Healthcare Services Small (1.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 1–5 < $100K 0–15% 0–15%
US Luminex Corp (LMNX)
Healthcare Services Small (1.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) -1–5 -$100K–$1M -0–15% 15–50%
Healthcare Services Small (1.7bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Small (1.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Small (1.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) 0 No activity — 0–15%
Healthcare Services Small (1.7bn) -1–5 -$10M–$100M -0–15% 50%+
Healthcare Services Small (1.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 1–5 < $100K 0–15% 15–50%
Healthcare Services Small (1.6bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Small (1.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 0 No activity — 0–15%
Healthcare Services Small (1.6bn) 0 No activity — 0–15%
Healthcare Services Small (1.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 0 No activity — 0–15%
US Innoviva Inc (INVA)
Pharmaceuticals & Medical Research Small (1.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 0 No activity — 0–15%
Healthcare Services Small (1.6bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Small (1.6bn) 0 No activity — 0–15%
Healthcare Services Small (1.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 0 No activity — 50%+
Healthcare Services Small (1.6bn) 0 No activity — 0–15%
Healthcare Services Small (1.6bn) -11–20 -$1M–$10M -0–15% 0–15%
US Absci Corp (ABSI)
Pharmaceuticals & Medical Research Small (1.6bn) 0 No activity — 0–15%
Healthcare Services Small (1.5bn) 1–5 $1M–$10M 0–15% 15–50%
Pharmaceuticals & Medical Research Small (1.5bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.5bn) 6–10 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.5bn) 0 No activity — —
Pharmaceuticals & Medical Research Small (1.5bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Small (1.5bn) -1–5 -< $100K -0–15% 15–50%